Pink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease
- PMID: 19088817
- DOI: 10.1139/G08-085
Pink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease
Abstract
Parkinson's disease (PD) is the most prevalent human neurodegenerative movement disorder and is characterized by a selective and progressive loss of the dopaminergic neurons. Mutations in the genes parkin and PTEN-induced putative kinase 1 (PINK1) result in autosomal recessive forms of PD. It has been suggested that parkin and Pink1 function in the same pathway in Drosophila, with Pink1 acting upstream of parkin. Previous work in our laboratory has shown the ability of parkin to rescue an alpha-synuclein-induced PD-like phenotype in Drosophila. To investigate the ability of Pink1 to protect against alpha-synuclein-induced toxicity, we have performed longevity, mobility, and histological studies to determine whether Drosophila Pink1 can rescue the alpha-synuclein phenotypes. We have found that overexpression of Pink1 results in the rescue of the alpha-synuclein-induced phenotype of premature loss of climbing ability, suppression of degeneration of the ommatidial array, and the suppression of alpha-synuclein-induced developmental defects in the Drosophila eye. These results mark the first demonstration of Pink1 counteracting PD phenotypes in a protein toxicity animal model, and they show that Pink1 is able to impart protection against potentially harmful proteins such as alpha-synuclein that would otherwise result in cellular stress.
Similar articles
-
Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.BMC Neurosci. 2004 Apr 16;5:14. doi: 10.1186/1471-2202-5-14. BMC Neurosci. 2004. PMID: 15090075 Free PMC article.
-
Expression of Pink1 with α-synuclein in the dopaminergic neurons of Drosophila leads to increases in both lifespan and healthspan.Genet Mol Res. 2012 May 21;11(2):1497-502. doi: 10.4238/2012.May.21.6. Genet Mol Res. 2012. PMID: 22653599
-
[Animal models for familial Parkinson's disease].Rinsho Shinkeigaku. 2007 Nov;47(11):938-40. Rinsho Shinkeigaku. 2007. PMID: 18210841 Japanese.
-
PINK1-Parkin signaling in Parkinson's disease: Lessons from Drosophila.Neurosci Res. 2020 Oct;159:40-46. doi: 10.1016/j.neures.2020.01.016. Epub 2020 Feb 6. Neurosci Res. 2020. PMID: 32035987 Review.
-
What have we learned from Drosophila models of Parkinson's disease?Prog Brain Res. 2010;184:3-16. doi: 10.1016/S0079-6123(10)84001-4. Prog Brain Res. 2010. PMID: 20887867 Review.
Cited by
-
Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential.Mol Neurodegener. 2023 Nov 11;18(1):83. doi: 10.1186/s13024-023-00676-7. Mol Neurodegener. 2023. PMID: 37951933 Free PMC article. Review.
-
Alpha-synuclein-associated changes in PINK1-PRKN-mediated mitophagy are disease context dependent.Brain Pathol. 2023 Sep;33(5):e13175. doi: 10.1111/bpa.13175. Epub 2023 May 31. Brain Pathol. 2023. PMID: 37259617 Free PMC article.
-
High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.PLoS One. 2015 Sep 11;10(9):e0137432. doi: 10.1371/journal.pone.0137432. eCollection 2015. PLoS One. 2015. PMID: 26361355 Free PMC article.
-
Genetic modifiers of synucleinopathies-lessons from experimental models.Oxf Open Neurosci. 2023 Mar 9;2:kvad001. doi: 10.1093/oons/kvad001. eCollection 2023. Oxf Open Neurosci. 2023. PMID: 38596238 Free PMC article. Review.
-
New insights on Parkinson's disease genes: the link between mitochondria impairment and neuroinflammation.J Neural Transm (Vienna). 2015 Oct;122(10):1409-19. doi: 10.1007/s00702-015-1399-z. Epub 2015 Apr 17. J Neural Transm (Vienna). 2015. PMID: 25894287 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
